Abstract #302005

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2002 Program page
JSM 2002 Abstract #302005
Activity Number: 230
Type: Luncheons
Date/Time: Tuesday, August 13, 2002 : 12:30 PM to 1:50 PM
Sponsor: WNAR
Abstract - #302005
Title: Software for Group Sequential Trials
Author(s): Scott Emerson*+ and Cyrus Mehta*+
Affiliation(s): University of Washington and Cytel Software Corporation
Address: Box 357232, Seattle, Washington, 98195, 675 Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA
Keywords:
Abstract:

Group sequential designs offer substantial benefits over traditional fixed-sample designs. This is especially important for Phase II and Phase III clinical trials, where ethical considerations such as patient safety and rapid approval of effective treatments are paramount. The FDA now recommends group sequential studies in certain cases. The discussion leaders are principal developers of the two leading software packages for group sequential design and monitoring, EaST and S+SeqTrial. Discussion will include current issues in the field, capability of existing packages, and future directions.

  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2002 program

JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002